Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
449.7 USD | +0.49% | +2.03% | +10.49% |
May. 22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
May. 21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.49% | 115B | |
+12.15% | 106B | |
-4.48% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.01% | 17.56B | |
-40.50% | 17.32B | |
+6.19% | 14.03B | |
+30.97% | 12.13B | |
-33.84% | 7.77B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $296 From $293, Maintains Neutral Rating